FDA Inspection 1187512 — StemCure, Inc.
The FDA completed an inspection of StemCure, Inc. on Nov 7, 2022 in Brooklyn, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Brooklyn, NY (United States)